Obesity and Gynecology, 2E

Total Page:16

File Type:pdf, Size:1020Kb

Obesity and Gynecology, 2E Obesity and Gynecology Obesity and Gynecology Second Edition Edited by Tahir A. Mahmood Victoria Hospital, Kirkcaldy, United Kingdom University of St. Andrews, St. Andrews, United Kingdom Sabaratnam Arulkumaran Division of Obstetrics and Gynaecology, St. George’s University of London, London, United Kingdom Frank A. Chervenak Lenox Hill Hospital, New York, NY, United States Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States Elsevier Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom 50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States Copyright © 2020 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www. elsevier.com/permissions. This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any informa- tion, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility. To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress ISBN: 978-0-12-817919-2 For Information on all Elsevier publications visit our website at https://www.elsevier.com/books-and-journals Publisher: Stacy Masucci Acquisitions Editor: Tari Broderick Editorial Project Manager: Sara Pianavilla Production Project Manager: Sreejith Viswanathan Cover Designer: Matthew Limbert Typeset by MPS Limited, Chennai, India Dedication To Aasia, Gayatri and Judy For their tolerance of our enthusiasm, support in times of happiness, succor in times of challenge, and endless love Tahir, Arul and Frank Contents List of contributors xiii Polycystic ovarian syndrome in adolescence 17 About the editors xvii Obstetric outcomes in obese adolescents 18 Preface—obesity in gynaecology xix Management principles 19 Management of polycystic ovarian syndrome in adolescence 20 Section 1 Psychological morbidity 21 Conclusion 21 Obesity and adolescence References 21 1. Obesity and the onset of 3. Obesity in polycystic ovary syndrome adolescence and infertility Zana Bumbuliene, Gabriele Tridenti and Ioannis E. Messinis, Christina I. Messini and Anastasia Vatopoulou Konstantinos Dafopoulos Obesity in childhood and adolescence: Introduction 23 definition 3 Obesity and infertility—possible mechanisms 23 Obesity in childhood and adolescence: Diet, lifestyle changes, and bariatric surgery 26 incidence 3 Clomiphene citrate 27 Obesity in children and adolescents: etiology 4 Aromatase inhibitors 28 Obesity and puberty: pathophysiology 7 Follicle-stimulating hormone 28 Obesity and pubertal development 8 Insulin sensitizers 29 Obesity in childhood and adolescence: clinical In vitro fertilization 29 manifestation 9 References 30 Obesity in children and adolescents: counseling 9 Obesity in children and adolescents: management 11 Section 2 References 11 Contraception 2. Obesity in adolescence 4. Obesity and sexual health Gail Busby and Mourad W. Seif Sharon Cameron and Michelle Cooper Introduction 15 Prevalence of childhood obesity: a global Introduction 37 perspective 15 Obesity and sexual behavior 37 Obesity and the pubertal transition 16 Obesity and sexual function 38 Factors affecting childhood and adolescent Obesity and sexual health outcomes 39 obesity 16 Conclusion 40 Adolescent obesity—adverse outcomes 16 References 40 vii viii Contents 5. Obesity and contraception Section 3 Sujeetha Damodaran and Krishnan Swaminathan Male and female Infertility Introduction 43 Risks of obesity in pregnancy 43 8. Obesity and hirsutism Classification of obesity based on body mass Mostafa Metwally index 43 Potential concerns with obesity and Introduction 77 contraception 43 Obesity and ovarian function 77 Obesity and contraceptive efficacy 44 Obesity and androgen production 77 Evidence (or lack of) for contraceptive Hirsutism 77 efficacy in overweight or obese women 45 Obesity and polycystic ovarian syndrome 78 Safety of hormonal contraceptives in obese The role of adrenal androgens in obese women women 46 with hirsutism 78 Obesity, contraception, and cardiovascular Management of hirsutism associated with disease 49 obesity 78 Obesity, contraception, and venous Treatment 79 thromboembolism 49 Conclusion 81 Obesity, contraception, and cancer 50 References 81 Contraceptive issues after bariatric surgery 50 Intrauterine contraceptive devices in obese women 51 Sterilization procedures in obese women 51 9. Obesity and female infertility References 52 Suresh Kini, Mythili Ramalingam and Tahir A. Mahmood 6. Contraceptive choices for women Introduction 83 before and after bariatric surgery Epidemiology 83 Pathophysiological basis of infertility in obese Agnieszka Jurga-Karwacka and Johannes Bitzer women 83 The clinical effects of obesity on female Introduction—Bariatric Surgery 57 infertility 85 Long acting contraceptives 58 Challenges of managing obese women 87 Progesterone-only injection 61 Treatment options 87 Oral hormonal contraception [56] 62 Conclusion 89 Progestogen-only pill 62 References 89 Safety and health benefits 62 Contraceptive patch and ring 63 Barrier method 63 Emergency contraception 63 10. Obesity and recurrent References 63 miscarriage Andrew C. Pearson and Tahir A. Mahmood 7. Long-term contraceptive care in obese Introduction 91 and superobese women Obesity and miscarriage 91 Johannes Bitzer Obesity and recurrent miscarriage 92 Polycystic ovarian syndrome 92 Introduction 67 Ovarian dysfunction 92 Combined hormonal contraceptives 67 Endometrial changes in obesity 93 Copper intrauterine device 68 Immunological factors 93 Levonorgestrel-containing intrauterine Male obesity and recurrent miscarriage 93 systems 69 Management 93 Etonogestrel-releasing implant 70 Conclusion 95 References 72 References 95 Contents ix 11. Obesity and assisted reproduction 15. Obesity, bariatric surgery, and male Mark Hamilton and Abha Maheshwari reproductive function Introduction 97 Man-wa Lui, Jyothis George and Prevalence of obesity in the assisted Richard A. Anderson reproduction sector 97 Introduction 135 Evidence of reduced fertility in the obese 97 Bariatric surgical techniques 135 Specific issues relating to assisted reproduction Pathophysiology in obesity 136 treatment 98 Obesity and spermatogenesis 138 Rationale for the use of assisted Obesity and Sertoli cell function 139 reproduction 98 Obesity and erectile dysfunction 139 Practical management of obese women Transgenerational epigenetic effects 139 undertaking assisted reproduction Practical considerations 139 treatment 99 References 140 Clinical procedures 99 Effect of obesity on the results of assisted reproduction treatment 100 16. Medical interventions to improve Safety issues for mothers and offspring 101 outcomes in infertile obese women Ethical issues relevant to access to services 102 planning for pregnancy Conclusion 103 References 103 Vikram Talaulikar Introduction 143 12. Obesity and sexual dysfunction in Impact of high body mass index on fertility and pregnancy 143 men Lifestyle interventions to improve outcomes in Darius A. Paduch and Laurent Vaucher infertile obese women planning for pregnancy 143 Physiology of sexual function 105 Dietary interventions 144 Sexual dysfunction and obesity-related Diet 144 comorbidities 110 Role of exercise 144 Multidisciplinary approach to treatment 113 Weight-loss medications and fertility outcomes 145 References 116 Metformin 145 Sibutramine 147 Orlistat 147 13. Male obesity—impact on semen Liraglutide 147 quality Barriers to weight loss 148 Conclusion 148 Vanessa Kay and Sarah Martins da Silva References 149 Introduction 119 Impact on semen quality 119 17. Surgical interventions to improve Combined semen parameters 120 fertility potential in obese men and Etiological theories 121 Treatment 123 women Conclusion 124 Joseph Chervenak and Frank A. Chervenak References 124 Introduction 151 Obesity and fertility 151 14. Evidence-based assisted reproduction Nonsurgical management of obesity 152 in obese women Bariatric surgery as a weight loss measure 152 Types of bariatric surgery 152 Brenda F Narice and Mostafa Metwally The impact of bariatric
Recommended publications
  • THE PHYSIOLOGY and ECOPHYSIOLOGY of EJACULATION Tropical and Subtropical Agroecosystems, Vol
    Tropical and Subtropical Agroecosystems E-ISSN: 1870-0462 [email protected] Universidad Autónoma de Yucatán México Lucio, R. A.; Cruz, Y.; Pichardo, A. I.; Fuentes-Morales, M. R.; Fuentes-Farias, A.L.; Molina-Cerón, M. L.; Gutiérrez-Ospina, G. THE PHYSIOLOGY AND ECOPHYSIOLOGY OF EJACULATION Tropical and Subtropical Agroecosystems, vol. 15, núm. 1, 2012, pp. S113-S127 Universidad Autónoma de Yucatán Mérida, Yucatán, México Available in: http://www.redalyc.org/articulo.oa?id=93924484010 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Tropical and Subtropical Agroecosystems, 15 (2012) SUP 1: S113 – S127 REVIEW [REVISIÓN] THE PHYSIOLOGY AND ECOPHYSIOLOGY OF EJACULATION [FISIOLOGÍA Y ECOFISIOLOGÍA DE LA EYACULACIÓN] R. A. Lucio1*, Y. Cruz1, A. I. Pichardo2, M. R. Fuentes-Morales1, A.L. Fuentes-Farias3, M. L. Molina-Cerón2 and G. Gutiérrez-Ospina2 1Centro Tlaxcala de Biología de la Conducta, Universidad Autónoma de Tlaxcala, Tlaxcala-Puebla km 1.5 s/n, Loma Xicotencatl, 90062, Tlaxcala, Tlax., México. 2Depto. Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México, D.F., México. 3Laboratorio de Ecofisiologia Animal, Departamento de Fisiologia, Instituto de Investigaciones sobre los Recursos Naturales, Universidad Michoacana de San Nicolás de Hidalgo, Av. San Juanito Itzicuaro s/n, Colonia Nueva Esperanza 58337, Morelia, Mich., México * Corresponding author ABSTRACT RESUMEN Different studies dealing with ejaculation view this Diferentes estudios enfocados en la eyaculación, process as a part of the male copulatory behavior.
    [Show full text]
  • Human Physiology/The Male Reproductive System 1 Human Physiology/The Male Reproductive System
    Human Physiology/The male reproductive system 1 Human Physiology/The male reproductive system ← The endocrine system — Human Physiology — The female reproductive system → Homeostasis — Cells — Integumentary — Nervous — Senses — Muscular — Blood — Cardiovascular — Immune — Urinary — Respiratory — Gastrointestinal — Nutrition — Endocrine — Reproduction (male) — Reproduction (female) — Pregnancy — Genetics — Development — Answers Introduction In simple terms, reproduction is the process by which organisms create descendants. This miracle is a characteristic that all living things have in common and sets them apart from nonliving things. But even though the reproductive system is essential to keeping a species alive, it is not essential to keeping an individual alive. In human reproduction, two kinds of sex cells or gametes are involved. Sperm, the male gamete, and an egg or ovum, the female gamete must meet in the female reproductive system to create a new individual. For reproduction to occur, both the female and male reproductive systems are essential. While both the female and male reproductive systems are involved with producing, nourishing and transporting either the egg or sperm, they are different in shape and structure. The male has reproductive organs, or genitals, that are both inside and outside the pelvis, while the female has reproductive organs entirely within the pelvis. The male reproductive system consists of the testes and a series of ducts and glands. Sperm are produced in the testes and are transported through the reproductive ducts. These ducts include the epididymis, ductus deferens, ejaculatory duct and urethra. The reproductive glands produce secretions that become part of semen, the fluid that is ejaculated from the urethra. These glands include the seminal vesicles, prostate gland, and bulbourethral glands.
    [Show full text]
  • Endometrial Scratch Trial
    PATIENT INFORMATION SHEET ENDOMETRIAL SCRATCH TRIAL. A Multicentre Randomised Controlled Trial of Induced Endometrial Scratch in Women Undergoing First Time in Vitro Fertilisation (IVF) Protocol Number: V7 (28/01/2019) ISRCTN Number: ISRCTN23800982 Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust Clinical Research Office Sheffield Royal Hallamshire Hospital D Floor Glossop Road Sheffield. S10 2JF Chief Investigator: Mostafa Metwally Local Principal Investigator: Dr Sarah Martins Da Silva Consultant Gynaecologist and Honorary Senior Lecturer Medical Research Institute Level 5 Ninewells Hospital and Medical School Dundee DD1 9SY [insert contact details] Introduction You are being invited to take part in a research trial. Before you decide it is important for you to understand why the research is being done and what it will involve. Please take time to read the following information carefully and discuss it with others if you wish. Ask us if there is anything that is not clear or if you would Generic PIS (Dundee only) V5.1 dated 15/03/2019 1 like more information. Take time to decide whether or not you wish to take part. Thank you for reading this. What is our research about? Taking a small amount of tissue from the lining of the womb (endometrium) can sometimes improve the chance of achieving a pregnancy in women who have previously had several unsuccessful attempts at In Vitro Fertilisation (IVF) or Intra- cytoplasmic sperm injection (ICSI). This procedure has been named “Endometrial Scratch” (ES). It is not known exactly why performing an Endometrial Scratch may be beneficial, but it is thought that the process of “scratching” the lining of the womb may release certain chemicals that are important in helping the fertilised egg (embryo) stick to the lining of the womb (implantation).
    [Show full text]
  • Gametogenesis: Spermatogenesis & Oogenesis -Structure of Sperm and Egg Fertilization
    Gametogenesis: Spermatogenesis & Oogenesis ‐Structure of Sperm and Egg Fertilization ‐ Definition, Mechanism Early development in Frog ‐ Cleavage, Blas tu la, GtlGastrula, DitiDerivatives of Germ layers Vikasana - CET 2012 y Human reproduction y Brief Account of Fertilization: Implantation, Placenta, Role of Gonadotropins and sex hormones , Menstrual cycle. y Fertility Control: Family Planning Methods- y Infertility Control: Meaning, Causes,Treatment y STD: AIDS , Syphilis and Gonorrhea Vikasana - CET 2012 1.Primary Oocyte is a) Haploid (n) b) Diploid (2n) c) Polyploid d) None of the above Vikasana - CET 2012 2.Secondary Oocyte is a) Haploid (n) b) Diploid (2n) c) Polyploid d) None of the above Vikasana - CET 2012 3.Centrioles of sperm control a) Movement of tail b) Hap lo id numb er of ch romosomes c) Help in fertilization d) None of the above. Vikasana - CET 2012 4.The Fertilization membrane is secreted because a) It checks the entry of more sperms after fertilization b) it checks the entry of antigens in ovum c))p it represents the left out tail of the sperm d) it represen tVikasanas the p - l CETasma 2012 mem brane of the sperm 5.Meiosis I occurs in a) Primary spermatocytes b) Secondary spermatocytes c) Both a and b d) Spermatogonia Vikasana - CET 2012 6.Meiosis II occurs in a) Secondary oocyte b))y Primary oocyte c) Spermatogonia d) Oogonia Vikasana - CET 2012 7.Axial filament of sperm is formed by a) Distal centriole b) Prox ima l centitrio le c) Mitochondria d) DNA Vikasana - CET 2012 8.Polar bodies are formed during a) oogenesis
    [Show full text]
  • Post Layout 1
    10 Established 1961 Analysis Monday, March 12, 2018 Established 1961 The First Daily in The Arabian Gulf THE LEADING INDEPENDENT DAILY IN THE ARABIAN GULF ESTABLISHED 1961 Founder and Publisher YOUSUF S. AL-ALYAN Editor-in-Chief ABD AL-RAHMAN AL-ALYAN EDITORIAL : 24833199-24833358-24833432 ADVERTISING : 24835616/7 FAX : 24835620/1 CIRCULATION : 24833199 Extn. 163 ACCOUNTS : 24835619 COMMERCIAL : 24835618 P.O.Box 1301 Safat,13014 Kuwait. E MAIL :[email protected] Website: www.kuwaittimes.net How infertility treatment has left sperm science behind hey can make test-tube babies, grow human eggs in a lab and reproduce mice from frozen Ttesticle tissue, but when it comes to knowing how a man’s sperm can swim to, find and fertilize an egg, scientists are still floundering. Enormous advances in treating infertility in recent decades have helped couples conceive longed-for offspring they previously would not have had. Yet this progress has also been a workaround for a major part of the problem: Sperm counts are falling drasti- cally worldwide - and have been doing so for decades - and scientists say their honest answer to Xi mandate seals march of strongmen why is: “We don’t know”. Infertility is a significant global health problem, he Chinese Communist Party’s decision to give Chinese model the country has taken a decisive turn away from the with specialists estimating that as many as one in six President Xi Jinping a mandate to rule for life is fur- Human rights campaigners warn that authoritarians idea of a more pluralistic society with greater political couples worldwide are affected.
    [Show full text]
  • Establishing Sexual Dimorphism in Humans
    CORE Metadata, citation and similar papers at core.ac.uk Coll. Antropol. 30 (2006) 3: 653–658 Review Establishing Sexual Dimorphism in Humans Roxani Angelopoulou, Giagkos Lavranos and Panagiota Manolakou Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece ABSTRACT Sexual dimorphism, i.e. the distinct recognition of only two sexes per species, is the phenotypic expression of a multi- stage procedure at chromosomal, gonadal, hormonal and behavioral level. Chromosomal – genetic sexual dimorphism refers to the presence of two identical (XX) or two different (XY) gonosomes in females and males, respectively. This is due to the distinct content of the X and Y-chromosomes in both genes and regulatory sequences, SRY being the key regulator. Hormones (AMH, testosterone, Insl3) secreted by the foetal testis (gonadal sexual dimorphism), impede Müller duct de- velopment, masculinize Wolff duct derivatives and are involved in testicular descent (hormonal sexual dimorphism). Steroid hormone receptors detected in the nervous system, link androgens with behavioral sexual dimorphism. Further- more, sex chromosome genes directly affect brain sexual dimorphism and this may precede gonadal differentiation. Key words: SRY, Insl3, testis differentiation, gonads, androgens, AMH, Müller / Wolff ducts, aromatase, brain, be- havioral sex Introduction Sex is a set model of anatomy and behavior, character- latter referring to the two identical gonosomes in each ized by the ability to contribute to the process of repro- diploid cell. duction. Although the latter is possible in the absence of sex or in its multiple presences, the most typical pattern The basis of sexual dimorphism in mammals derives and the one corresponding to humans is that of sexual di- from the evolution of the sex chromosomes2.
    [Show full text]
  • Female Tanner Stages (Sexual Maturity Rating)
    Strength of Recommendations Preventive Care Visits – 6 to 17 years Bold = Good Greig Health Record Update 2016 Italics = Fair Plain Text = consensus or Selected Guidelines and Resources – Page 3 inconclusive evidence The CRAFFT Screening Interview Begin: “I’m going to ask you a few questions that I ask all my patients. Please be honest. I will keep your Screening for Major Depressive Disorder -USPSTF answers confidential.” Age 12 years to 18 years 7 to 11 yrs No Yes Part A During the past 12 months did you: Screen (when systems in place for diagnosis, treatment and Insufficient 1. Drink any alcohol (more than a few sips)? □ □ follow-up) evidence 2. Smoked any marijuana or hashish? □ □ Risk factors- parental depression, co-morbid mental health or chronic medical 3. Used anything else to get high? (“anything else” includes illegal conditions, having experienced a major negative life event drugs, over the counter and prescription drugs and things that you sniff or “huff”) □ □ Tools-Patient Health Questionnaire for Adolescent(PHQ9-A) Tools For clinic use only: Did the patient answer “yes” to any questions in Part A? &Beck Depression Inventory-Primary Care version (BDI-PC) perform less No □ Yes □ well Ask CAR question only, then stop. Ask all 6 CRAFFT questions Treatment-Pharmacotherapy – fluoxetine (a SSRI) is Part B Have you ever ridden in a CAR driven by someone □ □ efficacious but SSRIs have a risk of suicidality – consider only (including yourself) who was ‘‘high’’ or had been using if clinical monitoring is possible. Psychotherapy alone or alcohol or drugs? combined with pharmacotherapy can be efficacious.
    [Show full text]
  • Module 10: Meiosis and Gametogenesis
    PEER-LED TEAM LEARNING INTRODUCTORY BIOLOGY MODULE 10: MEIOSIS AND GAMETOGENESIS JOSEPH G. GRISWOLD, PH.D. City College of New York, CUNY (retired) I. Introduction Most cells in our bodies have nuclei with 46 chromosomes organized in 23 homologous pairs. Because there are two chromosomes of each type, the cells are called diploid and 2N = 46. If mothers and fathers each passed 46 chromosomes to their offspring in reproducing, the children in the new generation would have 92 chromosomes apiece. In the following generation it would be 184. Obviously, the increase does not occur; normal people in each generation have the same 2N = 46. To produce a new individual (a zygote, initially) with 46 chromosomes, an egg and sperm each contribute half the total, or 23, when fertilization occurs. Both sperm and eggs, called gametes, develop from body cells in which the full 46 chromosomes are present. These body cells, located in the testes and ovaries, undergo special cell divisions, which reduce the number of chromosomes in half. The special cell divisions, two for each cell, make up a process called meiosis. Cells that have completed meiosis then differentiate to become gametes. The general objective of this laboratory is to learn how meiosis occurs in forming eggs and sperm to carry genetic information from one generation to the next. B. Benchmarks. 1. Demonstrate an understanding of the terminology of cellular genetic structure using diagrams. 2. Demonstrate the process of meiosis by using models or drawing chromosomes on cell outlines. 3. Compare the processes of mitosis and meiosis by: a. drawing diagrams with explanations of the processes, and b.
    [Show full text]
  • Longitudinal Antimullerian Hormone and Its Correlation with Pubertal
    UC San Diego UC San Diego Previously Published Works Title Longitudinal antimüllerian hormone and its correlation with pubertal milestones. Permalink https://escholarship.org/uc/item/7rw4337d Journal F&S reports, 2(2) ISSN 2666-3341 Authors Smith, Meghan B Ho, Jacqueline Ma, Lihong et al. Publication Date 2021-06-01 DOI 10.1016/j.xfre.2021.02.001 Peer reviewed eScholarship.org Powered by the California Digital Library University of California ORIGINAL ARTICLE: REPRODUCTIVE ENDOCRINOLOGY Longitudinal antimullerian€ hormone and its correlation with pubertal milestones Meghan B. Smith, M.D.,a Jacqueline Ho, MD, M.S.,a Lihong Ma, M.D.,a Miryoung Lee, Ph.D.,b Stefan A. Czerwinski, Ph.D.,b Tanya L. Glenn, M.D.,c David R. Cool, Ph.D.,c Pascal Gagneux, Ph.D.,f Frank Z. Stanczyk, Ph.D.,a Lynda K. McGinnis, Ph.D.,a and Steven R. Lindheim, M.D., M.M.M.c,d,e a Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California; b Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston, School of Public Health, Brownsville, Texas; c Department of Obstetrics and Gynecology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; d Center for Reproductive Medicine Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; e Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, People’s Republic of China; and f Department of Pathology, Glycobiology Research and Training center (GRTC), University of California San Diego, California Objective: To examine the changes in AMH levels longitudinally over time and their relationship with both body composition, partic- ularly abdominal adiposity, and milestones of pubertal development in female children.
    [Show full text]
  • Inside Front Cover October 7.Pmd
    Early Female Puberty: A Review of Research on Etiology and Implications Eileen Daniel and Linda F. Balog Abstract Though the age of menarche has not decreased signifi cantly over the past 40 years, on average, girls began The age of female puberty appears to have decreased in to develop breasts one to two years earlier during the same the United States and western countries as child health time frame. African American girls typically begin thelarche and nutrition have improved and obesity has become more by age 9 compared to age 10 for White girls, though prevalent. Also, environmental contaminants, particularly approximately 15% of African American girls and 5% of endocrine disruptors, may also play a role in lowering the age White girls begin breast budding between the ages of 7 and of puberty. Puberty at an early age increases the risk of stress, 8 (Slyper, 2006). Currently, around 50% of all girls in the poor school performance, teen pregnancy, eating disorders, U.S. have begun to develop breasts by age 10 and 14% by substance abuse, and a variety of health issues which may ages 8 and 9. appear later in life including breast cancer and heart disease. The typical age range for the onset of puberty is between Articles for this literature review were located using a 8 and 14 years in girls while early puberty occurs between 7 computerized search of the databases Health Reference and 9, and precocious puberty generally takes place before Center, Medline, PsycINFO, and ScienceDirect from 2000 the age of 6 or 7 (Carel & Leger, 2008).
    [Show full text]
  • Variability in the Length of Menstrual Cycles Within and Between Women - a Review of the Evidence Key Points
    Variability in the Length of Menstrual Cycles Within and Between Women - A Review of the Evidence Key Points • Mean cycle length ranges from 27.3 to 30.1 days between ages 20 and 40 years, follicular phase length is 13-15 days, and luteal phase length is less variable and averages 13-14 days1-3 • Menstrual cycle lengths vary most widely just after menarche and just before menopause primarily as cycles are anovulatory 1 • Mean length of follicular phase declines with age3,11 while luteal phase remains constant to menopause8 • The variability in menstrual cycle length is attributable to follicular phase length1,11 Introduction Follicular and luteal phase lengths Menstrual cycles are the re-occurring physiological – variability of menstrual cycle changes that happen in women of reproductive age. Menstrual cycles are counted from the first day of attributable to follicular phase menstrual flow and last until the day before the next onset of menses. It is generally assumed that the menstrual cycle lasts for 28 days, and this assumption Key Points is typically applied when dating pregnancy. However, there is variability between and within women with regard to the length of the menstrual cycle throughout • Follicular phase length averages 1,11,12 life. A woman who experiences variations of less than 8 13-15 days days between her longest and shortest cycle is considered normal. Irregular cycles are generally • Luteal phase length averages defined as having 8 to 20 days variation in length of 13-14 days1-3 cycle, whereas over 21 days variation in total cycle length is considered very irregular.
    [Show full text]
  • From Adrenarche to Aging of Adrenal Zona Reticularis: Precocious Female Adrenopause Onset
    ID: 20-0416 9 12 E Nunes-Souza et al. Precocious female 9:12 1212–1220 adrenopause onset RESEARCH From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset Emanuelle Nunes-Souza1,2,3, Mônica Evelise Silveira4, Monalisa Castilho Mendes1,2,3, Seigo Nagashima5,6, Caroline Busatta Vaz de Paula5,6, Guilherme Vieira Cavalcante da Silva5,6, Giovanna Silva Barbosa5,6, Julia Belgrowicz Martins1,2, Lúcia de Noronha5,6, Luana Lenzi7, José Renato Sales Barbosa1,3, Rayssa Danilow Fachin Donin3, Juliana Ferreira de Moura8, Gislaine Custódio2,4, Cleber Machado-Souza1,2,3, Enzo Lalli9 and Bonald Cavalcante de Figueiredo1,2,3,10 1Pelé Pequeno Príncipe Research Institute, Água Verde, Curitiba, Parana, Brazil 2Faculdades Pequeno Príncipe, Rebouças, Curitiba, Parana, Brazil 3Centro de Genética Molecular e Pesquisa do Câncer em Crianças (CEGEMPAC) at Universidade Federal do Paraná, Agostinho Leão Jr., Glória, Curitiba, Parana, Brazil 4Laboratório Central de Análises Clínicas, Hospital de Clínicas, Universidade Federal do Paraná, Centro, Curitiba, Paraná, Brazil 5Serviço de Anatomia Patológica, Hospital de Clínicas, Universidade Federal do Paraná, General Carneiro, Alto da Glória, Curitiba, Parana, Brazil 6Departamento de Medicina, PUC-PR, Prado Velho, Curitiba, Parana, Brazil 7Departamento de Análises Clínicas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil 8Pós Graduação em Microbiologia, Parasitologia e Patologia, Departamento de Patologia Básica – UFPR, Curitiba, Brazil 9Institut de Pharmacologie Moléculaire et Cellulaire CNRS, Sophia Antipolis, Valbonne, France 100Departamento de Saúde Coletiva, Universidade Federal do Paraná, Curitiba, Paraná, Brazil Correspondence should be addressed to B C de Figueiredo: [email protected] Abstract Objective: Adaptive changes in DHEA and sulfated-DHEA (DHEAS) production from adrenal zona reticularis (ZR) have been observed in normal and pathological conditions.
    [Show full text]